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RESEARCH PROJECT 
  
Tumor ablation by means of other than traditional surgical approaches is  a 
methodology attempted with modest success for a number of years. During the 
past few years however, the use of image-guided interventions in cancer treatment 
has experienced unparalleled growth. Modern approaches take advantage of the 
vastly superior armamentarium of imaging strategies now available. Advances in 
material science, and methods for delivery of ablating agents combined with 
improved localization now make possible to be much more aggressive and 
effective in attempting to achieve local ablation of malignant tumors. 
Interventional Oncology is gaining increasing acceptance as a viable alternate or 
complementary treatment for a variety of cancers. 
Ongoing research in industry and academic centers is focused on two clinical 
needs: to overcome limitations of current imaging modalities in guiding and 
monitoring ablation procedures and to produce larger zones of ablation in 
different organs in a safe and reproducible fashion.  
Ultrasound (US) is considered as imaging modality of choice for guiding 
percutaneous ablation procedures in the liver, with computed tomography (CT) 
guidance being reserved for lesions inconspicuous on US. However, there are 
occasions when the liver lesion is only optimally visualized on contrast-enhanced 
CT and magnetic resonance (MR) imaging, making targeting and monitoring 
difficult, due to lack of real-time imaging guidance. Given the advantages of US 
guidance, it would be ideal if the procedure can be performed with real-time US 
matched with supplementary information from contrast enhanced CT or MR 
images. Fusion imaging, the process of aligning and superimposing images 
obtained using two different imaging modalities, is a rapidly evolving field of 
interest, with its own specific operational conditions. The Phase I of this Research 
Project was designed to investigate the feasibility and validity of real-time 
guidance using a virtual navigation system that fused US and CT information in 
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targeting and ablating, by means of radiofrequency, a liver target inconspicuous 
on US. 
Phases II and III were designed to assess feasibility and safety of new ablative 
technologies in lung ablation in experimental animal models. In Phase II 
multitined perfused electrode needles were used to perform radiofrequency 
ablation of rabbit lung tissue. The potential benefits of using saline-enhanced RF 
ablation could be important in lung ablation, because of the tissue characteristics 
of the lung. In fact, air containing lung tissue has a naturally high tissue 
impedance, and this makes difficult to create a safety margin around the treated 
lesion . On the other hand, direct and uncontrollable thermal damage to adjacent 
and remote structures was observed more frequently using saline infusion during 
RF ablation than conventional RF ablation. The aims of Phase II were therefore to 
assess feasibility and safety of RF ablation of lung tissue performed with 
multitined perfused electrodes. 
Together with new RF devices, also alternative sources of energy are under 
investigation to overcome conventional RF ablation limits. With several theoretic 
and practical advantages, microwave (MW) ablation is a promising new option in 
the treatment of surgically unresectable tumors. The potential benefits of MW 
technology include consistently higher intratumoral temperatures, larger tumor 
ablation volumes, faster ablation times, improved convection profile and less 
procedural pain. Phase III was designed to know how MW ablation affects normal 
lung tissue, comparing a prototype MW ablation system with a commercially 
available RF device in an in-vivo lung rabbit model. 
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LIVER LESIONS TARGETING AND ABLATION WITH  A FUSION 
IMAGING SYSTEM: AN EXPERIMENTAL FEASIBILITY STUDY 
 
 
ABSTRACT 
 
Purpose: To investigate the feasibility and validity of real-time guidance using a 
fusion imaging system that combined ultrasound (US) and computed tomography 
(CT) in the targeting and subsequent radiofrequency (RF) ablation of a liver target 
inconspicuous on US. 
Methods and Materials: The study was designed as an experimental ex-vivo 
study in calf livers with radiopaque internal targets, inconspicuous at US, 
simulating a focal liver lesion. The study included two phases. The initial phase 
was to examine the feasibility of matching pre-procedural volumetric CT data of 
the calf livers with real-time US using a commercially available multimodality 
fusion imaging system (Virtual Navigator System, Esaote SpA, Genoa, Italy), and 
to assess the accuracy of targeting using a 22 gauge (G) cytological needle using 
the system. The second phase of the study was to validate such a technique using 
a 15G RF multitined expandable needle (RITA Medical Systems, Mountain View, 
CA) and to examine the accuracy of the needle placement relative to the target. 
Unenhanced CT of the liver and multiplanar reconstructions were performed to 
calculate respectively the distance between the needle and the pellet and the 
distance between the central tine of the RF electrode and the pellet. 
Results: All calf livers underwent successful CT-US registration with a mean 
registration error of 0.30 ± 0.01 cm and 0.29 ± 0.01 cm in the initial and second 
phase of the study, respectively. In the initial phase an overall number of 24 
insertions were performed following the US-CT guidance. The needle to target 
distance was 1.9 ± 0.7 mm (range 0.84-3 mm). In the second phase an overall 
number of 12 ablations were performed and only one insertion was done to place 
the electrode following the US-CT guidance. The mean target-central tine 
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distance, recorded at post-procedural CT, was 3.9 ± 0.7 mm (range 2.94-5.14 
mm).After the dissection of the specimen the pellet was found unchanged in the 
center of the ablation zone in all cases 
Conclusion: Real-time registration and fusion of pre-procedure CT volume 
images with intra-procedure US is feasible and accurate. For lesion hardly visible 
at US or CT or for more complex procedures, such as thermal tumor ablations that 
require positioning of multiple applicators and puncture of multiple lesions, 
navigation systems might be of help to reduce puncture risk and procedure time 
and to allow for more complete and radical therapy. 
 
 
INTRODUCTION 
 
Image guidance is essential in the treatment of liver tumors using percutaneous 
ablative techniques. Apart from careful pre-procedure planning and elaborate 
post-procedure evaluation, accurate intra-procedure targeting, monitoring, and 
controlling play a critical role in the success of the technique [1]. 
 In our centre radiofrequency (RF) ablation is most commonly performed under 
ultrasound (US) guidance, with computed tomography (CT) guidance being 
reserved for lesions inconspicuous on US. However, there are occasions when the 
liver lesion is only optimally visualized on contrast-enhanced CT and magnetic 
resonance (MR) imaging, making targeting and monitoring difficult due to lack of 
real-time imaging guidance. In this scenario, it would be desirable to fuse 
information from different imaging modalities (e.g., US and CT) and such 
multimodality matching have been utilized in nuclear medicine, radiotherapy, and 
neurosurgery [2-4] .  
In this study, we investigate the feasibility and validity of real-time guidance 
using a fusion imaging system that combined US and CT information in the 
targeting and subsequent RF ablation of a liver target inconspicuous on US. 
 
 7 
MATERIALS AND METHODS 
 
Study Design 
 
The study was designed as an experimental ex-vivo study in calf livers with 
radiopaque internal targets simulating a focal liver lesion. The approval by local 
Research Ethics Committee was obtained. The study included two phases. The 
initial phase was to examine the feasibility of matching pre-procedural volumetric 
CT data of the calf livers with real-time US using a commercially available 
multimodality fusion imaging system (Virtual Navigator System, Esaote SpA, 
Genoa, Italy), and to assess the accuracy of targeting using a 22 gauge (G) 
cytological needle using the system. The second phase of the study was to validate 
such a technique using a 15G RF multitined expandable needle and to examine 
the accuracy of the needle placement relative to the target. 
 
Target 
 
Radiopaque targets were represented by 1.5mm lead pellets, inconspicuous on 
conventional US but with high attenuation on CT. They allow realistic puncture 
by either of the needle types employed in our study. The pellet was implanted into 
calf liver, by using an 11 G soft introducer, 13 cm in length (StarBurst Soft Tissue 
Access System, RITA Medical System, Mountain View, CA). Soft introducers 
can be used with multitined expandable electrode needles, for the coagulation and 
ablation of soft tissue. They have a flexible sheath with a tapered tip and a blunt 
edge and a stainless steel stylet with three-face trocar point for cutting and dilation 
of tissue. In this study we used these introducers to place the bullets inside the calf 
liver. The introducer was inserted into the liver parenchyma from lateral liver 
side, to avoid the disruption of superior liver surface. After removing the stainless 
steel stylet, the pellet was put into the sheath and pushed inside the liver by means 
of the stylet. In each calf liver 4 pellets were inserted. 
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Fusion Imaging System  
 
The system consists of an US scanner connected to the Navigation unit. The two 
units are connected by a video cable to grab the ultrasound screen and a network 
cable to query the current scan geometry of the US scanner. An electromagnetic 
tracking system, composed by a transmitter and a small receiver (mounted on the 
US probe) provides the  position and orientation of  the US probe in relation to the 
transmitter. This permits a correct representation in size and orientation of the 
second modality image. These data are provided by the US scanner by the 
network connection and automatically updated at every change on the console of 
the Navigation unit. The system specifications are provided in Tab.1. 
The electromagnetic tracker is sensitive to metallic objects close or near the 
receiver or transmitter. Thus, any metallic material that may interfere and disturb 
the magnetic field must be avoided between the transmitter and the receiver.  
 
Fusion Imaging System Setup 
 
Prior to the intervention a four-step protocol was followed: 
1. Ten 1.5mm radio-opaque fiducial markers (X-Spots, Beekley, Bristol, CT) 
were applied to the calf liver capsule, in order to correlate (register) the CT 
scan with the US scan. 
2. Pre-procedure unenhanced multidetector CT (MDCT) of the liver was then 
performed using a 4-row scanner (LightSpeed Plus CT ,GE Medical 
Systems, Milwaukee, Wis) with a 1.25 mm collimation and a 
reconstruction interval of 0.6 mm, covering the external markers.  
3. The CT DICOM series were transferred to the Virtual Navigator System 
by using the Picture Archiving and Communicating System (PACS).  
4. The navigation system is coupled with an US machine (Technos MPX; 
Esaote, Genoa, Italy) and registration of the position of each fiducial 
marker to the system was executed in 2 stages. First the positions of all the 
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fiducial markers in the CT volume were identified and numbered (Figure 
1a). Secondly the corresponding positions on the cow livers were matched 
by applying point contact with a registration pin (Figure 1b) from the 
system on each marker. The sequence was in accordance with the number 
given during the first stage. Accuracy or error of registration will be 
displayed by the system following completion of registration of all the 10 
positions (Figure 1c). 
 
Real-time US of the calf livers was then performed using a 3.5Hz curvilinear 
probe with the images being displayed on the monitor of the Virtual Navigator 
System, next to the corresponding CT volumetric images. A sterilizable biopsy kit 
for convex array (ABS 421, Esaote, Genoa, Italy), with a biopsy needle angle of 
20° was used to guide the needle insertion. The US images could also be reverted 
to CT images on the same screen. Accuracy of the matched US-CT images was 
also subjectively assessed by the operator, using specific anatomical markers (i.e. 
air within liver vessels)  
 
Phase I: Targeting  
 
This was performed in 3 calf livers. The target was identified on the ‘real-time’ 
CT images during US assessment. As it was inconspicuous on US, the target was 
marked on the CT image and the corresponding location was pointed out by the 
system on the US image. The optimal biopsy route was chosen and a biopsy track 
was visualized (Fig. 2).  
A 21 G cytological needle 20 cm in length (Quinjekt, Hospital Service, Roma, 
Italy) was advanced into the liver parenchyma under real-time ultrasound 
visualization, with the attached biopsy kit (Fig. 3). The tip of the needle should 
ideally be placed in the target, but given the small dimensions and the solid nature 
of it, we considered to go the nearest as possible to the pellet. Two targeting 
procedures were performed per pellet, by two radiologists experienced in CT- and 
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US-guided percutaneous interventions. Only one needle pass had to be performed 
for each targeting procedure. The accuracy of targeting was assessed on a repeat 
CT examination with the needles in-situ. Unenhanced MDCT of the liver was 
performed with a 1.25 mm collimation and a reconstruction interval of 0.6 mm, 
covering the entire liver. The distance between the needle and the pellet was 
calculated on multiplanar reconstructed CT images (reconstruction interval of 1 
mm), along a plane perpendicular to the needle. 
  
Phase II: Radiofrequency ablation of the target 
 
RF ablation was performed in 3 calf livers. Target localization was performed and 
a 15 G RF multitined expandable electrode needle (Starburst XL, RITA Medical 
Systems, Mountain View, CA) was inserted into the liver using real-time 
guidance and biopsy kit, considering the target as the ideal centre of the ablation. 
The tip of the trocar was placed 1 cm from the centre of the intended ablation area 
(i.e. the pellet) for a 3 cm ablation, according to the manufacturer 
recommendations (Fig. 4). Following deployment of the tines to 3 cm, RF 
ablation was performed with a 200-W generator (model 1500; RITA Medical 
System, Mountain View, CA) at target temperature of 95 °C for 15 minutes. 
Continuous real-time US monitoring was performed during RF ablation. The 
target is heat resistant and therefore remained intact allowing visualization on a 
repeat CT post procedure. Only one needle pass had to be performed for each 
ablation procedure. Following ablation, the accuracy of targeting was assessed on 
a repeat CT examination with the needles in-situ. Unenhanced MDCT of the liver 
was performed with a 1.25 mm collimation and a reconstruction interval of 0.6 
mm, covering the entire liver. The distance between the central tine and the pellet 
was calculated on multiplanar reconstructed CT images (reconstruction interval of 
1 mm), along a plane perpendicular to the electrode. The liver was then cut along 
the electrode axis and the accuracy of RF targeting was assessed. 
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Results analysis 
 
Registration error due to matching misalignment is expressed in cm by the 
navigation system. Results are expressed as mean ± SD for continuous data. 
Target accuracy is defined as the distances in mm between the epicentre of the 
target and the Chiba needle in the first phase of the study, and the distances in mm 
between the epicentres of the target and the tip of the central tine of the multitined 
RF electrode needle in the second phase.  
 
 
RESULTS 
 
All calf livers underwent successful CT-US registration with a mean registration 
error of 0.30 ± 0.01 cm and 0.29 ± 0.01 cm in the initial and second phase of the 
study, respectively.  
After some experience in setting up the navigation system we were able to 
perform the system setup including the registration within 3-5 min.  
In phase I each pellet was used for two US-CT guided targeting insertions. An 
overall number of 24 insertions were performed with the aim of placing the Chiba 
needle the nearest as possible to the pellet, following the US-CT guidance. The 
needle to target distance was 1.9 ± 0.7 mm (range 0.84-3 mm) (Fig. 5). 
In phase II each pellet was used for one US-CT guided ablation. An overall 
number of 12 ablations were performed and only one insertion was done to place 
the electrode 1 cm from pellet, following the US-CT guidance. The mean target-
central tine distance, recorded at post-procedural CT, was 3.9 ± 0.7 mm (range 
2.94-5.14 mm). 
After the dissection of the specimen the pellet was found unchanged in the center 
of the ablation zone in all cases (Fig.6). 
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Table 1.  System specifications 
Module Description 
US Scanner Technos MPX  Esaote S.p.A 
US Probe Convex array 6-2 MHz 
Network connection TCP/IP protocol 
Navigation Unit  Virtual Navigator Esaote S.pA 
Tracking system PCIBirds (ASCENSION TECNOLOGY) Degrees 
of freedom: Six (position and orientation) 
Translation range, any direction: Standard 
transmitter = +/- 30 (76.2 cm) 
Angular range: All attitude 
Static accuracy standard sensor: .040 (1.0 mm) 
RMS position 
0.15 degree RMS orientation 
 
 
                          
 
 
 
 
       
 
a b 
Fig. 1(a-c). The positions of all the 
fiducial markers in the CT volume 
were identified and numbered (a). 
Then the corresponding positions on 
the calf livers are matched by 
applying point contact with a 
registration pin (b) from the system 
on each marker. Accuracy or error of 
registration is displayed by the 
system following completion of 
registration of all the 10 positions (c). 
 
c 
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Fig.2                                                              Fig.3 
                                          
                    Fig.4 
 
                   
 
Fig 5 (a,b) 
 
a b 
Fig. 2. The target is identified on the ‘real-time’ CT 
images during US assessment. The optimal biopsy 
route was chosen and a biopsy track was visualized. 
Fig.3. A 21 G cytological needle 20 cm in length is 
used, together  with the attached biopsy kit. In the 
back the matched US-CT image on the Virtual 
Navigator screen. 
Fig.4. The tip of the trocar has to placed 1 cm from the 
centre of the intended ablation area (i.e. the pellet) for 
a 3 cm  
Fig.5 (a,b).  Multiplanar reconstructed CT images 
showing the distance between the pellet and the needle 
that was inserted under US-CT guidance 
 
 14 
      
 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a b 
c d 
Fig. 6 (a-d). The target is identified on the ‘real-time’ CT images during US 
assessment and a 15 G RF multitined expandable electrode is inserted into the liver 
considering the target as the ideal centre of the ablation (a). Multiplanar 
reconstructed CT images show the relationship between the deployed hooks and the 
pellet (b) and the distance between the central tine and the pellet is calculated along 
a plane perpendicular to the electrode (c). After the dissection of the specimen the 
pellet is found unchanged in the center of the ablation zone (d) 
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DISCUSSION  
 
US is a widely used tool for imaging guided procedures in the abdomen, 
especially in the liver. US is fast, easily available, allows real time imaging and is 
characterized by high natural contrast among parenchyma, lesions, and vessels. 
On the other hand, because of its high spatial resolution, good contrast, wide field 
of view, good reproducibility, and applicability to bony and air-filled structures, 
CT plays an important role especially in interventions which cannot be adequately 
guided by fluoroscopy or US [5-7]. However, in contrast to fluoroscopy and US, 
CT has been limited by the lack of real-time imaging so that many CT-guided 
abdominal interventions remain difficult or risky in several locations [8]. 
Moreover, the contrast resolution of baseline CT scan is low and many liver 
lesions are visible only during arterial and/or portal-venous phase of the dynamic 
study and not uncommonly needle localization under un-enhanced phase of image 
guidance is based on nearby anatomical landmarks [9]. The introduction of CT 
fluoroscopy allows real-time display of CT images with a markedly decreased 
patient radiation dose and total procedure time comparable with the use of 
conventional CT guidance [10]. Moreover new systems of breath-hold monitoring 
have been implemented and  this could allow an easier access to mobile lesions 
[11]. However, despite marked improvements in procedure times compared with 
helical CT, CT fluoroscopy may still require 40% longer procedure times than US 
[12].  
Therefore the ideal qualities of a targeting technique during image-guided liver 
procedures include clear delineation of the tumour(s) and the surrounding 
anatomy, coupled with real-time imaging and multiplanar and interactive 
capabilities [1]. Given the advantage of US guidance, it would be ideal if the 
procedure can be performed with real-time US matched with supplementary 
information from contrast enhanced CT or MR images. Numerous devices have 
been constructed to improve puncture accuracy for percutaneous radiological 
interventions and majority of these are based on CT [13-17]. Image fusion, the 
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process of aligning and superimposing images obtained using two different 
imaging modalities, is a rapidly evolving field of interest, with its own specific 
operational conditions [18-20].   
To our knowledge this is the first report concerning the accuracy of targeting 
by using an image fusion system that matches real-time US and CT.  In our 
feasibility study, we demonstrated a high and consistent level of matching 
accuracy with mean registration error 0.30 ± 0.01 cm and 0.29 ± 0.01 cm in the 
initial and second phase of the study, respectively. Apart from external markers, 
registration of CT data to intra-procedure US images using specific anatomical 
(e.g., portal and hepatic veins) and topographical (xiphoid sternum and umbilicus) 
landmarks can also be accomplished in real-time during US examination. For 
anatomical matching, accuracy in defining the specific point pairs in both CT and 
US images is necessary to obtain the best registration results.  
We used a target that was undetectable at US and that was very small in size 
(1.5 mm). This ideally represents the situation of a tiny lesion that is visible only 
at CT. The navigation system represented therefore the only guidance for the 
procedures. By deciding to insert the needle only once for each targeting/ablation 
procedure, we reproduced the need of minimal invasiveness.  
Excellent target accuracy was achieved in both phases of the study, with an 
acceptable mean needle to target distance of  1.9 ± 0.7 mm (range 0.84-3 mm) in 
phase I and a mean target-central tine distance of 3.9 ± 0.7 mm (range 2.94-5.14 
mm) in phase II. Two our knowledge this is the first report about the accuracy of a 
fusion imaging system combining real time US with pre-acquired CT. 
The main limitation of the study is the absence respiratory excursion and 
subject motion in this ex-vivo model.  Either or both of these factors would 
introduce error but were not evaluated in our feasibility study. To extrapolate the 
utility in routine clinical practice, precise registration of CT volume images into 
the patient requires proper synchronisation with respect to the respiratory phase 
and arms’ position during CT examination, and patient movement must be 
avoided. We appreciate that added procedure time may be required to achieve 
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accurate patient registration in some cases, but this may be offset by the time 
taken to perform needle localization and RF ablation of a lesion invisible or 
poorly conspicuous on routine unenhanced US or CT. Possible solutions for 
detection of patient movement would be the implementation of external 
electromagnetic position sensors to the patient's body. To target liver lesions that 
move during the breathing cycle, a breathing motion correction must be 
implemented. The solution could be based on methods used in radiation therapy, 
as well as on those used in positron emission tomography–CT image fusion [21-
22].  
Future advances include the automation of registration, which could further 
streamline clinical translation of such technologies. Miniaturization of 
internalized sensors for electromagnetic tracking of needles and ablation probes 
will have the ability to transform image guided needle-based procedures by 
providing real-time multi-modality feedback. 
In conclusion real-time registration and fusion of pre-procedure CT volume 
images with intra-procedure US is feasible and accurate. For simple biopsies, an 
experienced interventionalist will not ask for such a guidance tool and, given the 
cost and availability, US and CT guidance will remain the "workhorses" for 
biopsy procedures. For lesion hardly visible at US or CT or for more complex 
procedures, such as thermal tumor ablations that require positioning of multiple 
applicators and puncture of multiple lesions, fusion imaging systems might be of 
help to reduce puncture risk and procedure time and to allow for more complete 
and radical therapy. 
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LUNG RADIOFREQUENCY ABLATION: IN-VIVO EXPERIMENTAL 
STUDY WITH PERFUSED MULTINED ELECTRODES 
 
ABSTRACT 
 
Purpose: To investigate feasibility and safety of lung radiofrequency (RF) 
ablation by using perfused expandable multi-tined electrodes in an in-vivo animal 
model 
Materials and Methods: Ten New Zealand White rabbits underwent RF ablation 
by using perfused expandable multi-tined electrodes (Starburst Talon, RITA 
Medical Systems, Mountain View, CA) and 200-W RF generator. The electrode 
was positioned under fluoroscopy guidance and a single percutaneous RF ablation 
was performed. Saline perfusate was doped with nonionic iodinated contrast agent 
to render it visible on computed tomography (CT). An immediate posttreatment 
CT scanning documented the distribution of the doped saline and the presence of 
immediate complications. The animals were monitored for delayed complications 
and sacrificed within 72 hours (n=4), two weeks (n=3), or four weeks (n=3). 
Assessment of ablation zone and adjacent structures was done at autopsy. 
Results: Major complications consisted of pneumothorax requiring drainage 
(n=2) and skin burn (n=1). Immediately after the procedure the area of ablation 
was depicted at CT as a round, well-demarcated area, homogenously opacified by 
iodinated contrast media. The presence of a sharply demarcated area of 
coagulation necrosis without severe damage to adjacent structures was confirmed 
at autopsy. In one case, in whom pneumothorax and pleural effusion were 
depicted, pleural fibrinous adhesions were demonstrated at autopsy. 
Conclusion: Lung RF ablation performed in an in-vivo animal model by using 
perfused expandable multi-tined electrodes is feasible and safe. No severe damage 
to adjacent structures was demonstrated. 
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INTRODUCTION 
 
Interventional Oncology is gaining increasing acceptance as a viable alternate or 
complementary treatment for a variety of cancers. Advances in material science, 
and methods for delivery of ablating agents combined with improved localization 
now make possible to be much more aggressive and effective in attempting to 
achieve local ablation of malignant tumors. Previous studies of saline-enhanced 
radiofrequency (RF) ablation of the liver have shown that the use of saline allows 
thermal energy to spread further and faster in tissue, and increases tissue ionicity, 
thereby permitting greater current flow [1, 2]. The potential benefits of using 
saline-enhanced RF ablation could be even more important in lung ablation, 
because of the tissue characteristics of the lung. In fact, air containing lung tissues 
has a naturally high tissue impedance, and this makes difficult to create a safety 
margin around the treated lesion [3-6].  
On the other hand, direct and uncontrollable thermal damage to adjacent and 
remote structures was observed more frequently using saline-enhanced RF 
ablation than with conventional RF in the liver. Saline injected during 
radiofrequency ablation can extravasate beyond the tumor, and this could result in 
an undesiderable extension of the ablation zone and complication [7]. 
The purpose of this investigation is to assess the technical feasibility and 
safety of percutaneous RF ablation in rabbit lung using a multitined perfused 
needle. 
 
  
MATERIALS AND METHODS  
 
STUDY DESIGN  
 
The study was designed as an experimental in-vivo study in rabbit lung. The 
research protocol was approved by the Animal Research Committe
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University before initiation of the study. All policies on humane care and use of 
laboratory animals were followed. 
Ten New Zealand White rabbits weighing about 3 Kg each were subjected to 
RF ablation. After the procedure the animals were carefully monitored for delayed 
complications and an intramuscolar injection of 100 mg of ampicillin (Amplisol®, 
Intervet Production, Milan, Italy) was administered from day 1 to day 5 after the 
procedure. Animals’ sacrifices were scheduled at 72 hours (n=4), 2 weeks (n=3) 
and 4 weeks (n=3) after the procedure.  
Following euthanasia, the lungs were harvested in toto, and gross pathology of 
the ablation zones and adjacent structures were performed.   
 
ABLATION DEVICES 
 
Experiments were performed by using a 200-W generator (model 1500; RITA 
Medical Systems, Mountain View, CA) and a 15 G RF multitined perfused 
electrode needle with a central active trocar and 4 side-deploying lateral tines 
(StarBurst Talon, RITA Medical Systems, Mountain View, CA) connected with a 
pump (IntelliFlow pump, RITA Medical Systems, Mountain View, CA) to deliver 
precise amount of saline to the ablation zone (Fig. 1). To perfuse the electrode we 
used a solution of 200cc of 0.9% NaCl saline doped 12:1 with nonionic iodinated 
contrast agent (Visipaque®, concentration, 320 mg/ml). The contrast agent, 
making the solution visible on CT, allowed us to evaluate the saline diffusion in 
tissues at the CT scan performed after the procedure. 
Before inserting the electrode the tines were perfused with the saline doped with 
the contrast agent at a high flow (0.7 ml/min) by selecting the “Purge mode” on 
the RF generator. As soon as the saline flowed out of all four tines the purge mode 
was stopped and the hooks retracted. The generator was put in the “Talon mode “ 
and the pump infused the saline doped with contrast agent into the lateral tines at 
a rate of 0.1ml/min. The planned ablation was of 3 minutes with the hooks 
deployed to 2 cm at a target temperature of 105 °C . 
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ABLATION PROCEDURES 
 
All rabbits were anesthetized by intravenous injection of  Zoletil® (tiletamine 
hypochloride+zolazepam hypochloride, 7 mg/kg) prior to procedures. Booster 
injections of up to one-half of the initial dose were administrated as needed. The 
rabbits were able to breath spontaneously during the procedures. The right 
thoracic wall of each animal were shaved and sterilized, and each animal was 
placed on left side. A grounding pad was placed in contact with a shaved area on 
the right haunch.  
A marker was placed on the animal’s skin at the level of the anticipated needle 
entry and the correct placement was checked by means of fluoroscopy. After 
cleansing the needle entry site with povidine-iodine solution a small stab incision 
was made with a scalpel to facilitate needle entry through the skin. The electrode 
was inserted directly into the lateral side of the right lower lobe. We chose this 
approach to reduce the chance of traversing interlobar fissures. After controlling 
under fluoroscopy the position of the needle in the lung, we deployed hooks up to 
2 cm, and we started the ablation (Fig.2). A dedicated software (RITA Base 
Software, RITA Medical Systems, Mountain View, CA) installed on a portable 
computer provided graph showing real-time curves of probe-tips temperatures, 
power output, and tissue impedance throughout the procedures (Fig.3). During the 
procedure, rabbits were carefully monitored for signs of respiratory distress or 
discomfort. Following ablation, the probe was removed slowly with a rotatory 
motion to minimize the potential for tissue disruption. 
 
POST-PROCEDURAL ASSESSMENT 
 
Immediate post-procedural CT scanning was obtained to document the 
distribution of the doped saline around the ablation zone and check for immediate 
complications. Axial scans (ST: 3 mm, SP: 1 mm, 120 kVp, 100 mA) of both the 
lung and upper abdomen, including the kidneys, were obtained. Intravenous 
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contrast material was not administered. Images were analyzed by using lung 
windows (level, -500 HU; width, 2000 HU) and soft-tissue windows (level, 50 
HU; width, 350 HU). 
 
Imaging Analysis 
Ablated lesions was evaluated in terms of location, size and shape, with particular 
attention to the contrast medium distribution around the ablation area. We 
evaluate also the presence of effusion in the pleural cavity or air in the pleural 
cavity or in soft tissues. The diameters of the ablated lesions were measured on 
PACS, on lung window images, by one radiologist using an electric caliper. To 
ensure that the changes noted were not present before RF ablation, the post- and 
preprocedural CT findings were compared. 
 
Histopathologic Examination 
After euthanasia the rabbits’ lungs and heart were harvested. The lung gross 
specimens obtained were dissected in planes similar to those of the CT scans, and 
were examined  measuring the central discolored region of coagulation necrosis in 
each pathologic specimen.  
 
 
RESULTS 
 
All procedures were technically successful (10/10 animals, 100% ) and completed 
according to protocol. Rabbits tolerated the procedure well. All rabbits awoke 
quickly from anesthesia, and normal activity and weight gain were observed 
during daily monitoring.  
Major complications occurring were pneumothorax  requiring drainage (n=2) 
and skin burn (n=1) (Fig.4). The pneumothoraces occurred acutely and were 
observed after needle insertion, before starting the ablations. A skin burn was 
observed in the right haunch of one rabbit when the grounding pad was removed. 
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Minor complications included mild pneumothorax (n=1) and pleural effusion 
(n=1) not requiring drainage, and pneumothorax with pleural effusion in the same 
animal (n=1) not requiring treatment. No delayed complications were observed. 
At the immediate postprocedural CT, a round well demarcated ablation zone 
(mean size 2.3 cm ± 0.8) is evident, with internal homogeneous distribution of 
iodinated contrast media in 10/10 cases (Fig.5). Iodinated contrast agent was not 
depicted at post-procedural CT  in adjacent lung parenchima, in bronchi, 
mediastinum, pleural or abdominal cavity (Fig.6). 
At gross pathology a clear-cut, sharply demarcated coagulation necrosis area 
(mean size, 2.1 cm ± 0.4) was evident (Fig.7). Clear-cut, sharply demarcated 
coagulation necrosis was observed in the animals sacrificed 72 hours or more after 
the procedure. Coagulation necrosis was initially surrounded by a reddish 
hyperemic rim. After 15 days, the hyperemic halo was no longer seen, and the 
lesion was surrounded by a firm, fibrotic, white peripheral rim. No significant 
differences at histopathology were demonstrated in ablation zone organization 
between specimen collected 2 and 4 weeks after the procedures. In all cases, lung 
parenchyma adjacent and far from the thermal lesion did not present any grossly 
apparent abnormality. In one case, in whom pneumothorax and pleural effusion 
were depicted, pleural fibrinous adhesions were demonstrated at autopsy (Fig.8). 
No severe damage of organs adjacent to the lungs was observed. In particular 
heart, pericardium and diaphragm were non injured (Fig.8). Major arterial and 
venous pulmonary vessels were preserved, in the absence of sign of thrombosis or 
parietal damage. 
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 Fig. 1(a,b). 15 G RF multitined perfused electrode needle with a central active 
trocar and 4 side-deploying lateral tines (a) was connected with a 200-W 
generator and a with a pump (b) 
 
Fig. 2. The electrode was placed 
under fluoroscopy guidance and the 
times were deployed to 2 cm 
Fig. 3. A dedicated software i 
provided graph showing real-time 
curves of probe-tips temperatures 
 Fig. 4. Severe pneumothorax  that 
occurred immediately after needle 
insertion, before starting ablation 
 
a b 
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a b c 
Fig. 5 (a-c). At the immediate postprocedural CT, a round well demarcated 
ablation zone is evident, with internal homogeneous distribution of iodinated 
contrast media 
Fig. 6 (a-d). After electrode placement in 
the right lower lobe and the deployment of 
the hooks under fluoroscopy guidance (a) 
the ablation is started. At the end of the 
ablation an opacified area was depicted ar 
fluoroscopy (b). At the immediate 
postprocedural CT, a round well 
demarcated ablation zone is 
evident,opacified by the iodinated 
contrast media (c). Contrast media was 
not depicted in pleural cavity . 
a b c 
d 
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Fig. 7. At gross pathology a clear-cut, sharply demarcated coagulation 
necrosis area was evident 
Fig. 8 (a,b). Lung parenchyma adjacent and far from the thermal lesion did 
not present any grossly apparent abnormality (a). In one case, in whom 
pneumothorax and pleural effusion were depicted, pleural fibrinous 
adhesions were demonstrated at autopsy (b). 
a b 
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DISCUSSION 
 
Lung cancer is among the most common malignancies in the world and is the 
leading cause of cancer death [8, 9]. For patients with stage I and II non-small cell 
lung cancer (NSCLC), surgical resection is usually regarded as the treatment of 
choice. The most frequent reasons for denying surgery in these patients are 
associated comorbidity, patient refusal to undergo surgery, or advanced age. The 
presence of severe comorbidity in NSCLC patients is increasing owing to the 
increase of lung cancer incidence among the elderly as a consequence of increased 
life expectancy [10-12]. In addition, NSCLC tends to recur even after successful 
resection [13].  Chemotherapy and radiation therapy protocols are used to treat 
patients with non-operable or unresectable tumors, but have not been entirely 
satisfactory in terms of long-term survival outcomes [12, 14].  
Lungs are also the second most frequent site of metastatic disease. There have 
been multiple series documenting survival benefits in patients with pulmonary 
metastases of favourable histology who were completely resected as compared to 
unresectable individuals [15,16]. However, surgery is frequently precluded by the 
number and location of metastatic nodules. Moreover, the high risk of recurrence 
in patients with metastatic disease and the need to remove functioning lung tissue 
along with the lesions limit the indications for surgery [17]. In these cases, 
radiation therapy and palliative chemotherapy are offered. Yet, both of these 
treatment options can further damage the pulmonary parenchyma and offer little 
hope for a cure [18]. Therefore, new modalities for local treatment that effectively 
destroy tumor but are less invasive and less damaging to normal lung tissue are 
required. 
Percutaneous RF ablation is presently the most frequently used technique to 
treat solid tumors, thanks to its effectiveness, safety and relative ease of use. 
Because of its ability to produce large volumes of coagulation necrosis in a 
controlled fashion, this technique has gained acceptance as viable therapeutic 
option for unresectable liver malignancies [19,20]. Recently, investigation has 
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been focused on the clinical application of RF ablation in the treatment of lung 
malignancies [21-23]. Lencioni et al. [24] reported the results of a multicenter trial 
in which 106 patients with 186 malignant lung tumors 3.5 cm in diameter or 
smaller were treated. Diagnoses included NSCLC in 33 patients, metastasis from 
colorectal cancer in 53, and metastasis from other primary malignancy in 20. 
Complete ablation of macroscopic tumor as shown by 3-month CT was achieved 
in 173 of 186 tumors (primary effectiveness rate, 93%), with an overall survival 
was 69% and 49% at 1 and 2 years respectively in patients with NSCLC; 86% and 
62% at 1 and 2 years in patients with colorectal cancer metastases. Cancer-
specific survival was 91% and 91% at 1 and 2 years in patients with NSCLC; 88% 
and 72% at 1 and 2 years in patients with colorectal metastases. 
A limitation of RF ablation is that, as temperatures reach 100° C and boiling 
occurs, increased impedance limits further deposition of electricity into tissue 
[25]. This becomes even more pronounced if charring occurs; the resultant eschar 
forms a highly effective insulator around the electrode. In addition air containing 
lung tissue has a naturally high impedance. Several different types of electrodes 
have been developed to avoid this effect and increase tissue heating and 
coagulation during RF ablation. These include internal water-cooling, and multi-
tined electrode designs [26-27]. Saline injected either before or during RF ablation 
has also been used to increase the size of the ablation zone [28]. Saline acts as a 
wet electrode increasing the total effective electrode size, reduces tissue 
dehydration and charring, and hence produces a larger ablation zone [29,30]. It 
was however noted that adjunctive saline resulted in a more irregular ablation 
zone and that saline can extravasate beyond the tumor. With the high-perfusion-
rate system this could result in an undesirable extension of the ablation zone and a 
complication [7, 31, 32].  
Our concern was that saline infused during RF ablation of lung tumors may not 
always be confined to the tumor. Our aim was to demonstrate the distribution of 
saline after ablation with perfused electrodes in an experimental animal model.  
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In our study all procedures were technically successful and the animals well 
tolerated the procedures. Severe and mild pneumothoraces, the most frequent 
complication, were puncture-related  and occurred before starting the ablation. 
Therefore they were not related to the infusion of saline during RF ablation. No 
delayed complications were observed. At the immediate postprocedural CT, a 
round well demarcated ablation zone was evident, with internal homogeneous 
distribution of iodinated contrast media in all cases. Iodinated contrast agent was 
not depicted at post-procedural CT  in adjacent lung parenchima, in bronchi, 
mediastinum, pleural or abdominal cavity. These findings were confirmed at 
autopsy where lung parenchyma adjacent and far from the thermal lesion did not 
present any grossly apparent abnormality and no severe damage of organs 
adjacent to the lungs was observed. In particular heart, pericardium and 
diaphragm were non injured. Major arterial and venous pulmonary vessels were 
preserved, in the absence of sign of thrombosis or parietal damage. The safety of 
the procedure could be related to the controlled, slow infusion of saline during 
ablation. The dedicated infusion pump allows the lateral tines to be perfused by 
saline with a slow, constant flow of 0,1 ml/min. To our knowledge this is the first 
report concerning the use of Talon electrode combined with Intellyflow pump in 
lung tissue. The micro-perfusion could represent the most important factor to 
guarantee the safety of the procedure.  
 A study performed in rabbit lung showed that saline infusion during lung RF 
ablation was associated with lower impedance, higher power delivery and larger 
lesion size  [6]. In this study the incidence of complications, and in particular of 
pneumothoraces, tended to be higher in the group of animals submitted to RF and 
saline instillation, even if the difference was not statistically significant. The 
reason was probably in the fact that the Author used a Chiba needle to infuse the 
saline and thus they punctured at least twice the pleura. However the shape of the 
ablation zone was spherical using small amounts of saline, and this was probably 
due, as in our study, to the slow flow of saline infusion that was approximately of 
0.05 ml/min. When RF ablation was performed in the porcine lung using a 
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perfusion electrode with a relatively high flow of saline (1.5 ml/min) it was in fact 
demonstrated that the coagulation volume was larger that that obtained with 
internally cooled or multitined expandable electrodes, but that the ablation zone 
had irregular margins [33].  
Our study has however some limitations. First, the results obtained in healthy 
rabbit lung may differ from those obtained with non-small-cell lung carcinoma or 
lung metastses in humans. Second, the safety of the procedure was evaluated 
clinically and on the basis of  post procedural CT and gross pathology 
examination, without performing histological examination. We were however not 
assessing the ability of the device to produce ablation in lung tissue: In view of 
the small size of rabbit lungs Talon electrode was deployed to 2 cm, actually half 
its maximum deplyment. Third, since the 15G electrode used in this study is large 
for rabbits, with their relatively smaller lungs, the complication rates of RFA 
might be overestimated.  
In conclusion, CT-guided percutaneous RF ablation performed with perfused 
multitined electrodes is feasible and safe. Saline-enhanced RF ablation might be a 
promising technique for the management of inoperable lung malignancies and has 
the potential for use as a minimally invasive approach. To determine whether the 
technique can be feasibly and safely used to produce a sufficiently large volume 
of necrosis to be of value in the treatment of small peripheral lung tumors in 
patients for whom surgery or palliative radiotherapy is unsuitable, further study 
using a larger animal model is warranted. 
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THERMAL ABLATION OF THE LUNG: IN VIVO EXPERIMENTAL 
COMPARISON OF MICROWAVE AND RADIOFREQUENCY 
 
ABSTRACT 
 
Purpose: To compare feasibility, safety and effectiveness of microwave (MW) 
ablation versus radiofrequency (RF) ablation in a lung rabbit model. 
Methods and Materials: Twenty New Zealand White rabbits were submitted to 
either MW ablation (n=10, group A) or RF ablation (n=10, group B). A single 
percutaneous ablation of lung tissue was performed in each animal under 
computed tomography (CT) guidance. The procedures were carried out with a 
prototype MW ablation device (Vivawave; Tyco Healthcare) and a commercially 
available RF ablation system (Cool-tip; Tyco Healthcare). Animals’ sacrifices 
were scheduled at 3 days (group A, n=5; group B, n=5) and 7 days (group A, n=5; 
group B, n=5) after the procedure. Gross pathology and microscopic assessment 
of the ablation zones and adjacent structures were performed.   
Results: Technical success was achieved in 9/10 rabbits in group A and 9/10 
rabbits in group B. Technical failures were related to intra-procedural animal 
death due to anaesthesiology stress (n=1, group A) and severe pneumothorax 
(n=1, group B). One rabbit of group B died 24 hours after the procedure because 
of massive hemothorax. Complications included pneumothorax (group A, n=4; 
group B, n=4), abscess (group A, n=1; group B, n=1), and thoracic wall burn 
(group A, n=4). The mean diameter of the ablation zone on gross examination 
were 12.1mm ± 3.2 in group A and 14.8 mm ± 4.9 in group B (p=0.2). At 
histopathology, zones of thermal injuries in group A and B were similar, with 
septal necrosis, edema, hemorrhage and peripheral lymphocytic infiltrate. 
Thrombosis of small vessels surrounding the ablation zone was extensively 
depicted in group A specimens and focally present in group B specimens. No 
severe damage of adjacent organs was observed. 
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Conclusion: Feasibility and safety of MW ablation are similar to those of RF 
ablation in a lung rabbit model. MW and RF ablated zones are similar in 
pathologic appearance. MW ablation produces a greater damage to peripheral 
small vessels inducing thrombosis. 
 
 
INTRODUCTION 
 
Radiofrequency (RF) ablation is a relatively new minimally invasive technique 
used to treat solid tumors. It has become a desired image-guided ablative method 
because of its ability to produce large regions of coagulative necrosis in a 
controlled fashion. Following recent advances in the RF technology, RF ablation 
has gained an increasingly important role in the treatment of unresectable hepatic 
malignancies, and is challenging partial hepatectomy as the treatment of choice 
for patients with limited hepatic tumor [1-3]. Despite the experience with RF 
ablation of malignant tumors outside the liver being at an early stage of clinical 
application, recent studies have shown that this technique could offer a valuable 
treatment option for unresectable lung malignancies [4-10].  
However, RF ablation is fundamentally restricted by the need to conduct 
electric energy into the body. As temperatures reach 100°C and boiling occurs, 
increased impedance limits further deposition of electricity into tissue [11]. This 
becomes even more pronounced if charring occurs. A further limitation of RF 
ablation is the relatively small zone of active heating created by ionic agitation 
[12]. The majority of tissue heating is thus due to thermal conduction, which 
decreases exponentially away from the source. The high rate of local recurrence 
seen in some clinical series of RF ablation is almost certainly caused in part by the 
protective effect of blood flow in the liver, termed the “heat-sink effect” [13].  
With several theoretic and practical advantages, microwave (MW) ablation is a 
promising new option in the treatment of surgically unresectable tumors. The 
potential benefits of MW technology include consistently higher intratumoral 
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temperatures, larger tumor ablation volumes, faster ablation times, improved 
convection profile and less procedural pain [14-17]. Because the cooling effect of 
blood flow is most pronounced within the zone of conductive rather than active 
heating, a larger power field may also enhance treatment of perivascular tissue 
[16,17]. Recent advances in MW engineering have allowed the design of new 
MW systems with the potential for larger, more controlled ablation zones. We 
considered it essential to know how MW ablation affects normal lung tissue 
before performing clinically for peripheral lung malignancies. An experimental 
study was deemed necessary to evaluate the thermal response, coagulation extent, 
and histological changes in the air-filled normal lung. Demonstration of the ability 
of MW ablation to destroy normal lung tissue is clinically relevant, as it would 
enable creation of a safety margin of ablation of pulmonary parenchyma around 
lung tumors, which is expected to result in higher rates of complete tumor 
eradication and lower rates of local recurrence. Thus, the purpose of our study was 
to compare a prototype MW ablation system with a commercially available RF 
device in an in-vivo lung rabbit model. 
 
 
METHODS AND MATERIALS 
 
STUDY DESIGN  
 
Our institutional Animal Research Committee gave protocol approval for this 
study. All policies on humane care and use of laboratory animals were followed. 
Twenty New Zealand White rabbits were divided into two groups. Group A 
(n=10) was submitted to single percutaneous MW ablation. Group B (n=10) 
received single percutaneous RF ablation.  
After the procedure the animals were carefully monitored for delayed 
complications and an intramuscolar injection of 100 mg of ampicillin (Amplisol®, 
Intervet Production, Milan, Italy) was administered from day 1 to day 5 after the 
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procedure. Animals’ sacrifices were scheduled at 3 days (group A, n=5; group B, 
n=5) and 7 days (group A, n=5; group B, n=5) after the procedure.  
Following euthanasia, the lungs were harvested in toto, and gross pathology 
and microscopic assessment of the ablation zones and adjacent structures were 
performed.   
 
ABLATION DEVICES 
 
The MW ablation device used in this study is a prototype developed by Tyco 
Healthcare. The antenna is a 15-gauge coaxial dipole design with a 1.6-cm 
exposed tip (Vivawave, Tyco Healthcare). A MW generator is used to drive the 
system at 915 MHz, with power output controlled by means of a laptop computer 
with custom software. MW ablation was planned to be performed at a power of 45 
W for a duration of 10 minutes.   
RF ablation was performed with a 17-gauge, 2-cm exposed-tip RF electrode 
(Cool-tip, Tyco Healthcare). Ablation area was created using a RF generator 
capable of producing 200 W power. Tissue impedance was monitored by circuitry 
incorporated within the generator. A peristaltic pump was used to infuse normal 
saline solution at 0° C into the lumen of the electrode at a rate of 10-25 ml/min. 
RF ablation was planned to be performed for a duration of 12 minutes. 
 
ABLATION PROCEDURES 
 
All rabbits were anesthetized by intravenous injection of  7 mg/kg of tiletamine 
hypochloride+zolazepam hypochloride (Zoletil®) prior to procedures. Booster 
injections of up to one-half of the initial dose were administrated as needed. The 
rabbits were able to breath spontaneously during the procedures. 
The right thoracic wall of each animal were shaved and sterilized, and each 
animal was placed on left side. In group B rabbits a pediatric grounding pad was 
placed in contact with a shaved area on the right haunch. Positioning of the 
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grounding pad was adjusted to minimize initial circuit impedance. In group A 
animals, who underwent MW ablation, positioning of grounding pad is not 
necessary because of the inherent properties of the electromagnetic wave. 
Both MW and RF procedures were performed following standard rules for 
computed tomography (CT)-guided lung biopsy. CT scanning was performed with 
a dedicated machine for experimental studies (CT Sytec 3000, GE Medical 
System) operating in standard axial mode. Parameters included 5mm section 
collimation, 120 kVp, 100 mA and a high resolution matrix filter. A marker was 
placed on the animal’s skin avoiding the great dorsal vein, at the level of the 
anticipated needle entry, and the correct placement was checked by means of CT. 
After cleansing the needle entry site with povidine-iodine solution, a small stab 
incision was made with a scalpel to facilitate needle entry through the skin. The 
electrode was inserted directly into the lateral side of the right lower lobe. We 
chose this approach to reduce the chance of traversing interlobar fissures (Fig. 1). 
During the procedure, rabbits were carefully monitored for signs of respiratory 
distress or discomfort. Following ablation, the probe was removed slowly with a 
rotatory motion to minimize the potential for tissue disruption. 
 
POST-PROCEDURAL ASSESSMENT 
 
Using the same scanner, immediate post-procedural CT scanning was obtained to 
assess the ablation zone and check for immediate complications. Axial scans 
(5mm section collimation, 120 kVp, 100 mA) of both the lung and upper 
abdomen, including the kidneys, were obtained. Intravenous contrast material was 
not administered. Images were analyzed by using lung windows (level, -500 HU; 
width, 2000 HU) and soft-tissue windows (level, 50 HU; width, 350 HU). 
 
Imaging Analysis 
Each MW and RF ablation zones was evaluated in terms of its location, size and 
shape, attenuation change, and the presence of effusion in the pleural cavity or air 
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in the pleural cavity or in soft tissues. The diameters of the ablated lesions were 
measured on lung window images, by one radiologist, using an electronic caliper. 
To ensure that the noted changes were not present before MW and RF ablation, 
the pre- and postprocedural and CT findings were compared. 
 
Histopathologic Examination 
After euthanasia the rabbits’ lungs and heart were harvested en-block. The lung 
gross specimens obtained were dissected in planes similar to those of the CT 
scans, and were examined. For macroscopic examination, the pathologist 
measured the central discolored region of coagulation necrosis in each pathologic 
specimen. Tissues were then fixed in 10% formalin for routine histological 
examination, and final processing for light microscopic study involved paraffin 
sectioning and haematoxylin-eosin (HE) staining. Tissues obtained from all 
treatment areas were analyzed for non-viability, their histological appearance, and 
demarcation from surrounding viable tissue.  
 
DATA ANALYSIS 
 
The technical aspects of MW and RF ablation and complications arising after both 
kind of procedures were compared. The size of the MW and RF ablation zones at 
immediate CT scan and at pathology were compared using an unpaired Student’s t 
test. For statistical analysis, JMP 5.0.1.2 computer software (SAS Institute Inc, 
Cary, NC, USA) was used and a p value of less than 0.05 was considered 
statistically significant. 
 
 
RESULTS 
 
Technical success was achieved in 9/10 rabbits in group A and 9/10 rabbits in 
group B. Technical failure in group A was related to intra-procedural animal death 
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due to anaesthesiology stress. The animal expired at 6 minutes after the start of 
the procedure and ablation was allowed to complete. Post-procedural CT 
demonstrated no pneumothorax and the animal was autopsied immediately. After 
inspection of the thoracic cavity, there appeared to be a normal ablation that did 
not involve the heart.  The section was removed and was analyzed for histology. 
Technical failure in group B was due to severe pneumothorax, causing electrode 
misplacement. Percutaneous drainage was performed but the pneumothorax 
remained severe and the animal died. 
One rabbit of group B died 24 hours after the procedure because of massive 
hemothorax, that was depicted at CT performed immediately after the procedure 
and confirmed at autopsy (Fig. 2).  
Complications included pneumothorax (group A, n=4; group B, n=4), abscess 
(group A, n=1; group B, n=1), and thoracic wall burn (group A, n=4). All 
pneumothoraces occurred acutely and were observed after needle insertion, before 
starting the ablations. Pneumothoraces observed in group A were all of mild entity 
and did not require any specific treatment. All the procedures were completed in 
these animals. One out of four pneumothoraces observed in group B animals was 
severe and needed drainage. The animal was rescheduled for the RF procedure 
that was successfully performed 2 weeks later. In 3 cases the pneumothoraces 
were limited and managed conservatively (Fig. 3). 
Both the abscesses occurred in the periprocedural period, and were 
demonstrated at autopsy performed 7 days after the procedure. Purulent material 
was present in the right emithorax of one rabbit of the group submitted to MW 
and in one animal submitted to RF (Fig. 4a). The appearance and the entity of the 
abscesses were similar in the two animals. 
Thoracic wall burns were observed in 4 out of 10 animals in group A (Fig. 4b). 
All of them were in the site of needle entry where, during the procedure, the skin 
was heated up together with the needle shaft and the cable. 
MW and RF ablation zones were indistinguishable at immediate CT. 
Immediately after MW or RF ablation, a restricted area of central dense opacity 
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enclosed by an extensive area of ground-glass opacity was noted in the ablated 
region on CT images (Fig. 5).  
The mean longest diameter of the ablated lesions at CT images acquired 
immediately after the procedure were 18.8 ± 5.4 mm in group A and 20.4 ± 4.0 
mm in group B (p=0.3). 
At autopsy, no severe damage of organs adjacent to the lungs was observed. In 
particular heart, pericardium and diaphragm were non injured. Major arterial and 
venous pulmonary vessels were preserved, in the absence of sign of thrombosis or 
parietal damage. 
The mean longest diameter of the ablation zone on gross examination was 
12.1mm ± 3.2 in group A and 14.8 mm ± 4.9 in group B (p=0.2). At 
histopathology, zones of thermal injuries in group A and B were similar, with 
septal necrosis, edema, hemorrhage and peripheral lymphocytic infiltrate (Fig. 6). 
No significant differences at histopathology were demonstrated in ablation zone 
organization between specimen collected at 3 and 7 days after the procedures. 
Thrombosis of small vessels surrounding the ablation zone was extensively 
depicted in group A specimens and focally present in group B specimens (Fig. 7).  
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Fig.1 
   
Fig.2 
           
a b 
c 
a 
Fig. 1 (a-c). After shaving the right 
thoracic wall and cleansing the needle 
entry site with povidine-iodine solution  
(a) , the MW (b) and RF (c) electrodes 
were inserted under CT guidance in the 
right lower lobe of the rabbit lung. 
Fig.2 (a,b). One rabbit of group B died 
24 hours after the procedure because of 
massive hemothorax, that was depicted 
at CT performed immediately after the 
procedure (a) and confirmed at autopsy 
(b).  
a b 
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a b 
Fig. 3 (a,b). Pneumothorax of mild entity in a rabbit of the group submitted to MW 
(a). Severe pneumothorax in an animal submitted to RF.  
Fig. 4 (a,b). Purulent material in the right emithorax of one rabbit of the group 
submitted to MW (a); thoracic wall burn (b) in one animal of the MW group   
a 
Fig. 5 (a,b). MW (a) and RF (b) ablation zones were indistinguishable at immediate 
CT   
a b 
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a b 
d c 
a b c 
Fig. 6 (a-d). Similar findings of septal necrosis, edema, hemorrhage were depicted 
at histopathology in specimens collected both 3 and 7 days after MW (a) and RF (b).  
Lymphocytic infiltrate was present peripherally in specimens of the two groups (c, 
MW; d, RF) 
Fig. 7 (a-c). Thrombosis of small vessels surrounding the ablation zone was 
extensively depicted in specimens of animal submitted to MW (a). In animals 
submitted to RF vessels without thrombosis (b) together with vessels with partial 
thrombosis (c) were depicted. 
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DISCUSSION 
 
Lung cancer is among the most common malignancies in the world and is the 
leading cause of cancer death [18, 19]. Surgical resection is the treatment of 
choice for early-stage non-small cell lung cancer (NSCLC). Unfortunately, 
patients with early-stage NSCLC are sometimes poor surgical candidates, because 
of co-existent chronic obstructive bronchopneumopathy or other associated 
diseases [20-22]. In addition, NSCLC tends to recur even after successful 
resection [23]. Thanks to widespread use of CT small pulmonary nodules (3 cm or 
less in diameter) are now being diagnosed more frequently [18, 19, 24, 25]. 
Chemotherapy and radiation therapy protocols are used to treat patients with non-
operable or unresectable tumors, but have not been entirely satisfactory in terms 
of long-term survival outcomes [22,26].  
Lungs are also the second most frequent site of metastatic disease. There have 
been multiple series documenting survival benefits in patients with pulmonary 
metastases of favourable histology who were completely resected as compared to 
unresectable individuals [27, 28]. However, surgery is frequently precluded by the 
number and location of metastatic nodules. Moreover, the high risk of recurrence 
in patients with metastatic disease and the need to remove functioning lung tissue 
along with the lesions limit the indications for surgery [29]. In these cases, 
radiation therapy and palliative chemotherapy are offered. Yet, both of these 
treatment options can further damage the pulmonary parenchyma and offer little 
hope for a cure [30]. Therefore, new modalities for local treatment that effectively 
destroy tumor but are less invasive and less damaging to normal lung tissue are 
required. 
Percutaneous RF ablation is presently the most frequently used technique to 
treat solid tumors, thanks to its effectiveness, safety and relative ease of use. 
Because of its ability to produce large volumes of coagulation necrosis in a 
controlled fashion, this technique has gained acceptance as viable therapeutic 
option for unresectable liver malignancies [1, 3, 31]. Recently, investigation has 
b 
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been focused on the clinical application of RF ablation in the treatment of lung 
malignancies [32-36]. Lencioni et al. [37] reported the preliminary results of a 
multicenter trial in which 106 patients with 186 malignant lung tumors 3.5 cm in 
diameter or smaller were treated. Diagnoses included NSCLC in 33 patients, 
metastasis from colorectal cancer in 53, and metastasis from other primary 
malignancy in 20. Complete ablation of macroscopic tumor as shown by 3-month 
CT was achieved in 173 of 186 tumors (primary effectiveness rate, 93%). Overall 
survival was 69% and 49% at 1 and 2 years respectively in patients with NSCLC; 
86% and 62% at 1 and 2 years in patients with colorectal cancer metastases. 
Cancer-specific survival was 91% and 91% at 1 and 2 years in patients with 
NSCLC; 88% and 72% at 1 and 2 years in patients with colorectal metastases. 
A limitation of RF ablation is the relatively small zone of active heating created 
by ionic agitation (on the order of a few millimetres) [12]. The majority of tissue 
heating is thus due to thermal conduction, which decreases exponentially away 
from the source. This results in an inefficient transformation of electrical energy 
into heat, especially at tissue-vessel interfaces where flowing blood thermally 
protects perivascular tissue and tumor [38]. Moreover, as temperatures reach 100° 
C and boiling occurs, increased impedance limits further deposition of electricity 
into tissue [11]. This becomes even more pronounced if charring occurs; the 
resultant eschar forms a highly effective insulator around the electrode. A number 
of different algorithms of energy deposition and several different types of 
electrodes are used to minimize this effect [39-41]. 
MW ablation seems to offer many of the advantages of RF ablation while 
possibly overcoming some of the limitations. MW radiation refers to the region of 
the electromagnetic spectrum with frequencies from 900 to 2450 MHz. This type 
of radiation lies between infrared radiation and radio waves. Water molecules are 
polar; that is, the electric charges on the molecules are not symmetric. The 
alignment and the charges on the atoms are such that the hydrogen side of the 
molecule has a positive charge, and the oxygen side has a negative charge [42]. 
Electromagnetic radiation has electric charge as well; the “wave” representation is 
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actually the electric charge on the wave as it flips between positive and negative. 
For a microwave oscillating at 9.2 x 108 Hz, the charge changes signs nearly 2 
billion times a second (9.2 x 108 Hz). When an oscillating electric charge from 
radiation interacts with a water molecule, it causes the molecule to flip. MW 
radiation is specially tuned to the natural frequency of water molecules to 
maximize this interaction. As a result of the radiation hitting the molecules, the 
electrical charge on the water molecule flips back and forth 2-5 billion times a 
second depending on the frequency of the MW energy. Temperature is a measure 
of how fast molecules move in a substance, and the vigorous movement of water 
molecules raises the temperature of water. Therefore, electromagnetic microwaves 
heat matter by agitating water molecules in the surrounding tissue, producing 
friction and heat, thus inducing cellular death via coagulation necrosis [42].  
The literature is sparse regarding morphological changes in tissue after MW 
coagulation therapy, despite a relatively long history of its use since 1979 [43]. It 
is very important the finding that MW ablation is less affected by the presence of 
blood vessels than is RF ablation. The majority of tissue heating at RF ablation is 
caused by thermal conduction, which computer modelling suggests is affected 
greatly by the heat-sink effect of local blood flow [38]. MW ablation, on the other 
hand, has a much larger zone of active heating, with the area of active heating 
being a function of the wavelength of the applied energy [44, 45]. A recent 
comparative study of RF versus MW ablation in a hepatic porcine model has 
reported that RF ablation was deflected by 26% in the presence of local blood 
vessels, while MW ablation was deflected by only 4 % [46]. 
Certainly, RF can generate larger zones of ablation with cluster electrodes, 
larger multitined expandable electrodes, or perfusion electrodes. Similarly, MW 
can create a larger zones of ablation with larger or multiple probes. Recently, a 
prototype loop-shaped MW antenna was developed that, in animal studies of 
hepatic tumors, more effectively kills tumors. MW ablation with the loop probes 
results in complete tumor kill at the ablation/tumor interface, and adjacent to 
surrounding blood vessels. In addition, vessels within the ablation/tumor interface 
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failed to show viable cells. The shape of the lesions was not distorted by the 
proximity to blood vessels. The advantages of this configuration over 
conventional straight probes include the ability to encircle a tumor, deliver large 
amounts of precisely targeted MW energy to the tumor, and spare normal liver 
outside the loop [47]. 
Several  reports regarding MW ablation in the treatment of hepatocellular 
carcinoma and colorectal metastases, and the showed  promising results [48-51]. 
To our knowledge there are not any clinical trials reported in literature 
regarding the clinical use of MW ablation in lung tumors. There are few published 
data from experimental studies, concerning the expected size, quality and 
pathologic changes of MW ablation in lung tissue. An experimental study in 
normal canine lung tissue demonstrated that the temperature in lung parenchyma 
increased to 90-100° C at 5mm from the electrode after 60 sec, and 70-80° C at 
10mm after 90 sec at 40 or 60 W. The coagulation area was approximately 20mm 
in diameter at 40 W and 60 W. The authors concluded the optimal condition in 
clinical percutaneous MW coagulation therapy to be 40-60 W for 3-4 min of 
coagulation. Through these parameters, histological findings shortly after MW 
coagulation showed degeneration and thickening of collagen fiber and exfoliation 
and ulceration of bronchial epithelium surrounding the electrode [52]. 
Our study was designed to assess feasibility, safety and effectiveness of MW 
ablation in an animal model. A comparison with the most widely used image-
guided ablative technique, i.e. RF ablation, was also performed. In theory, lung 
tumors are well suited to MW as well as to RF ablation because the surrounding 
air in adjacent normal parenchyma provides an insulating effect, thus facilitating 
energy concentration within the tumor tissue. In fact the dielectric heat energy 
cannot be generated in the presence of air and selective tumor damage may be 
achieved, with limited damage to the surrounding normal air-filled lung tissue. 
Feasibility and safety of MW ablation are similar to those of RF ablation in our 
study, performed in a lung rabbit model. Technical success was achieved in 9/10 
rabbits in MW ablation group and 9/10 rabbits in RF ablation group. In both cases 
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technical failure was not due to the ablative procedure but to the anaesthesiology 
stress in the first case and to pneumothorax after lung puncture in the second case. 
One death was encountered in the study. A massive emothorax, depicted at CT 
scan performed immediately after the procedure, represented the cause of death, 
that was confirmed at autopsy.  
The pneumothorax rate was similar in the two groups of animals, as 4 cases 
were observed in the MW ablation group and 4 cases were demonstrated in the RF 
ablation. In one case, in the RF ablation group, drainage was required, while the 
remaining pneumothoraces and in particular those observed in MW group were all 
of mild entity and did not require any specific treatment. Also the abscess rate is 
similar in the two groups (1 per group) and they developed in spite of the 
antibiotic therapy. 
Interestingly, thoracic wall burns were observed in 4 out of 10 animals in MW 
group. All of them were in the site of needle entry where, during the procedure, 
the skin was heated up together with the needle shaft and the cable. A possible 
explanation was given by the retrospective inspection of initial probe positioning 
at CT images. It revealed that the proximal edge of the exposed tip was probably 
in contact with the chest wall at the scar site, causing thermal injury to chest wall. 
Another possible explanation is that the direct heating produced by MW was not 
sufficiently concentrated at the needle tip. This could be due to the fact that the 
device is still prototypal and needs to be improved. However at autopsy, no severe 
damage of organs adjacent to the lungs was observed and major arterial and 
venous pulmonary vessels were preserved, in the absence of sign of thrombosis or 
parietal damage. Therefore the heat production and the ablation zone is well 
demarcated at the tip of the electrode, with no serious risk of damage of important 
structures located beyond the needle tip. 
MW and RF ablation zones were indistinguishable at immediate CT and their 
mean longest diameter was not significantly different. It has however to be taken 
into consideration that the exposed tip of the two electrodes were slightly different 
(1.6 cm for MW and 2 cm for RF electrodes). This could mean a slight increase in 
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the size of ablation zone produced by MW when compared to RF ablation. 
The mean longest diameter of the ablation zones were similar also on gross 
examination: 12.1mm ± 3.2 and 14.8 mm ± 4.9 respectively for MW and RF 
ablation. These sizes were however different from those measured at CT, 
immediately after the procedure. The possible explanations are that at CT we 
measure both the ablation zone and a peri-ablation area of hemorrhagic suffusion. 
At 3 and 7 days after the procedure, when the pathological specimens were 
collected, these phenomenon was decreased and at pathology it is easy to 
distinguish the necrotic zone from the peripheral hemorrhagic area.   
At histopathology, zones of thermal injuries in MW and RF group were 
similar, with septal necrosis, edema, hemorrhage and peripheral lymphocytic 
infiltrate. No significant differences at histopathology were demonstrated in 
ablation zone organization between specimen collected at 3 and 7 days after the 
procedures. Thrombosis of small vessels surrounding the ablation zone was 
extensively depicted in MW ablation specimens and focally present in RF ablation 
specimens. This finding seems to demonstrate the claim that MW ablation is less 
affected by the presence of  small blood vessels than is RF ablation. Improved 
performance near blood vessels may be caused by the large zone of active heating 
at MW ablation in comparison to the relative dependence of RF ablation on 
passive thermal conduction. Alternatively, high temperatures generated at MW 
ablation may overcome the cooling effect of blood flow. The improved 
performance of MW ablation near small blood vessels, combined with the ability 
to use multiple simultaneous probes, could make MW ablation a promising 
alternative to conventional ablative therapies. If local tumor recurrence is often 
due to survival of tumor cells near local blood vessels, MW ablation may help 
reduce recurrence following ablative therapy. The demonstration of the ability of 
MW ablation to destroy lung tissue located in the proximity of large vessels 
would greatly expand the indication for clinical use and would enable successful 
treatment of lesions that are difficult to eradicate by RF ablation.  
Assessment of any early/late damage to arterial or venous vessels when 
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ablating adjacent lung parenchyma is crucial to prevent fatal/major complications 
in clinical use. A study with a larger animal model would therefore be needed to 
evaluate the safety and effectiveness of MW ablation in ablating central areas of 
the lung located in the proximity or adjacent to arterial and venous 
vessels/airways and to assess the presence/absence/degree of the heat sink effect 
in MW ablation. 
In conclusion, feasibility and safety of MW ablation are similar to those of RF 
ablation in a lung rabbit model. MW and RF ablation zones are similar in 
pathologic appearance. MW ablation produces a greater damage to peripheral 
small vessels inducing thrombosis. Demonstration of the ability of MW ablation 
to destroy normal lung tissue is clinically relevant, as it would enable creation of a 
safety margin of ablation of pulmonary parenchyma around lung tumors, which is 
expected to result in higher rates of complete tumor eradication and lower rates of 
local recurrence. These findings represent a promising background for future 
studies investigating the ability and the safety of MW ablation in ablating central 
areas of the lung located in the proximity or adjacent to arterial and venous 
vessels/airways. Demonstration of the ability of MW ablation to destroy lung 
tissue located the proximity of large vessels would greatly expand the indication 
for clinical use and would enable successful treatment of lesions that are difficult 
to eradicate by RF ablation. Comparison between the MW and RF ablation will 
moreover enable development of precise indications/contraindications for each 
technique in clinical use.  
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